Doctor profile · Federal record

Dr. Gerardo Trillo, M.D.

Medical Oncology Physician (CMS: Medical Oncology) · Frisco, TX

  • NPI 1770521387
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 45 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4461 Coit RD, Suite 100
Frisco, TX 750350521
(972) 987-1975
fax (972) 335-0712
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
July 13, 2011
Year of graduation
1981 — 45 yrs since
Specialty taxonomy
207RX0202X — NUCC code
State license (1)
Texas #H8875
Medicaid (4)
TX #134651202 · TX #134651211 · OK #100041920A · TX #134651213

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1770521387. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
119,293
Distinct HCPCS
10
Medicare allowed
$879,763
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 28,560 28 $0
J1756 Injection, iron sucrose, 1 mg 20,500 21 $0
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram 18,480 12 $0
J1453 Injection, fosaprepitant, 1 mg 13,950 18 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 13,435 16 $3
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg 9,060 18 $42
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,632 37 $0
36415 Insertion of needle into vein for collection of blood sample 1,481 471 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,260 448 $8
J1626 Injection, granisetron hydrochloride, 100 mcg 1,210 14 $0

In context: peer comparison

Among 1 peers in Frisco Medical Oncology Physician, average services per provider: 2,650. This provider delivers 45× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,250
Transactions
48
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Astellas Pharma US INC 3 $215.43
Pfizer INC. 8 $154.72
Daiichi Sankyo INC. 10 $142.96
AstraZeneca Pharmaceuticals Lp 3 $77.93
Novartis Pharmaceuticals Corporation 4 $75.34
Merck Sharp & Dohme LLC 3 $73.16
Gilead Sciences, INC. 3 $64.08
Genzyme Corporation 2 $47.63
E.R. Squibb & Sons, L.L.C. 2 $47.26
Abbvie INC. 2 $42.64
Tempus Ai, INC 2 $42.57
BeiGene USA, INC. 2 $38.84
Celgene Corporation 2 $33.34
Aveo Pharmaceuticals, INC. 1 $30.24
Deciphera Pharmaceuticals INC. 1 $29.87

By nature of payment

Food and Beverage
$1,050
Education
$200

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
852
Patients
177
Total drug cost
$849,821
Drug Type Claims Patients Total cost
Xarelto (Rivaroxaban) Brand 144 30 $138,785
Dexamethasone Generic 82 25 $1,278
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 78 18 $1,140
Warfarin Sodium Generic 76 15 $1,353
Tamoxifen Citrate Generic 69 18 $2,093
Clopidogrel (Clopidogrel Bisulfate) Brand 67 19 $808
Acyclovir Generic 56 11 $969
Eliquis (Apixaban) Brand 47 15 $49,058
Meloxicam Generic 46 0 $294
Prednisone Generic 45 15 $281

Frequently asked questions

Auto-generated from federal data
What is Dr. Gerardo Trillo's medical specialty?
Dr. Gerardo Trillo practices Medical Oncology Physician in Frisco, TX.
Where does Dr. Gerardo Trillo practice?
Dr. Gerardo Trillo practices at 4461 Coit RD, Frisco, TX 750350521. Office phone: 9729871975.
What is Dr. Gerardo Trillo's NPI?
Dr. Gerardo Trillo's National Provider Identifier (NPI) is 1770521387, issued by NPPES.
Does Dr. Gerardo Trillo accept Medicare assignment?
Yes. Dr. Gerardo Trillo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gerardo Trillo commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110). Source: CMS Medicare Physician & Other Practitioners file.